Taiho Oncology is a Princeton-based oncology company focused on developing and commercializing orally administered small-molecule anti-cancer agents for solid tumors and hematologic malignancies. Leveraging a robust pipeline that spans multiple clinical stages, the firm aims to improve outcomes for patients, families, and caregivers. As a subsidiary of Taiho Pharmaceutical and part of Otsuka Holdings, Taiho Oncology benefits from deep scientific expertise and global resources, with operations in the U.S., Europe, and Canada. Its distinctive approach combines innovative oral therapeutics with a commitment to patient-centric care, positioning it as a leader in targeted cancer treatment.
Taiho Oncology is seeking a Director, Regulatory Affairs CMC to join their team in Princeton, NJ. The successful candidate will play a pivotal role in advancing CMC strategy and submissions for developmental, life cycle, and post-approval projects globally, while working with colleagues in Japan and the US to help cancer patients.
Taiho Oncology is a Princeton-based oncology company focused on developing and commercializing orally administered small-molecule anti-cancer agents for solid tumors and hematologic malignancies. Leveraging a robust pipeline that spans multiple clinical stages, the firm aims to improve outcomes for patients, families, and caregivers. As a subsidiary of Taiho Pharmaceutical and part of Otsuka Holdings, Taiho Oncology benefits from deep scientific expertise and global resources, with operations in the U.S., Europe, and Canada. Its distinctive approach combines innovative oral therapeutics with a commitment to patient-centric care, positioning it as a leader in targeted cancer treatment.
Olema Oncology